TABLE OF CONTENTS
Volume 15, Issue 6 (June 2008)
Review
Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
A W Tong and J Nemunaitis
Cancer Gene Ther 15: 341-355; advance online publication, March 28, 2008; doi:10.1038/cgt.2008.8
Original Articles
Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway
S Shamimi-Noori, W-S Yeow, M F Ziauddin, H Xin, T L N Tran, J Xie, A Loehfelm, P Patel, J Yang, D S Schrump, B L Fang and D M Nguyen
Cancer Gene Ther 15: 356-370; advance online publication, February 29, 2008; doi:10.1038/sj.cgt.7701120
Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy
M Guan, V Tripathi, X Zhou and N C Popescu
Cancer Gene Ther 15: 371-381; advance online publication, March 28, 2008; doi:10.1038/cgt.2008.13
Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression
S Li, J Yang, F A Urban, J N MacGregor, D P M Hughes, A E Chang, K T Mcdonagh and Q Li
Cancer Gene Ther 15: 382-392; advance online publication, February 22, 2008; doi:10.1038/cgt.2008.5
Tumor-targeting prodrug-activating bacteria for cancer therapy
C-M Cheng, Y-L Lu, K-H Chuang, W-C Hung, J Shiea, Y-C Su, C-H Kao, B-M Chen, S Roffler and T-L Cheng
Cancer Gene Ther 15: 393-401; advance online publication, March 28, 2008; doi:10.1038/cgt.2008.10
Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells
R Wang, F Lin, X Wang, P Gao, K Dong, A-M Zou, S-Y Cheng, S-H Wei and H-Z Zhang
Cancer Gene Ther 15: 402-412; advance online publication, March 14, 2008; doi:10.1038/cgt.2008.16
